# A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

> **NCT00700063** · PHASE2 · COMPLETED · sponsor: **Peplin** · enrollment: 265 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** PEP005 Topical Gel
- **DRUG:** PEP005 Topical Gel
- **DRUG:** PEP005 Topical Gel
- **DRUG:** Vehicle gel
- **DRUG:** PEP005 Topical Gel
- **DRUG:** PEP005 Topical Gel
- **DRUG:** PEP005 Topical Gel
- **DRUG:** Vehicle gel

## Key facts

- **NCT ID:** NCT00700063
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00700063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00700063, "A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00700063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*